These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 18489929

  • 1. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock.
    Dominguez-Rodriguez A, Samimi-Fard S, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Kaski JC.
    Am J Cardiol; 2008 Jun 01; 101(11):1537-40. PubMed ID: 18489929
    [Abstract] [Full Text] [Related]

  • 2. Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Samimi-Fard S, Dominguez-Rodriguez A, Abreu-Gonzalez P, Enjuanes-Grau C, Blanco-Palacios G, Hernandez-Baldomero IF, Bosa-Ojeda F, Marrero-Rodríguez F.
    Am J Cardiol; 2009 Sep 01; 104(5):634-7. PubMed ID: 19699336
    [Abstract] [Full Text] [Related]

  • 3. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
    Vis MM, Sjauw KD, van der Schaaf RJ, Baan J, Koch KT, DeVries JH, Tijssen JG, de Winter RJ, Piek JJ, Henriques JP.
    Am Heart J; 2007 Dec 01; 154(6):1184-90. PubMed ID: 18035093
    [Abstract] [Full Text] [Related]

  • 4. Distortion of the terminal portion of the QRS is predictor of shock after primary percutaneous coronary intervention for acute myocardial infarction.
    Garcia-Rubira JC, Garcia-Borbolla R, Nuñez-Gil I, Manzano MC, Garcia-Romero MM, Fernandez-Ortiz A, Perez de Isla L, Macaya C.
    Int J Cardiol; 2008 Nov 12; 130(2):241-5. PubMed ID: 18068246
    [Abstract] [Full Text] [Related]

  • 5. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
    Pres D, Gasior M, Strojek K, Gierlotka M, Hawranek M, Lekston A, Wilczek K, Tajstra M, Gumprecht J, Poloński L.
    Kardiol Pol; 2010 Jul 12; 68(7):743-51. PubMed ID: 20648428
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock.
    Valente S, Lazzeri C, Vecchio S, Giglioli C, Margheri M, Bernardo P, Comeglio M, Chiocchini S, Gensini GF.
    Int J Cardiol; 2007 Jan 08; 114(2):176-82. PubMed ID: 16737749
    [Abstract] [Full Text] [Related]

  • 9. Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission.
    Marenzi G, Assanelli E, Campodonico J, De Metrio M, Lauri G, Marana I, Moltrasio M, Rubino M, Veglia F, Montorsi P, Bartorelli AL.
    Crit Care Med; 2010 Feb 08; 38(2):438-44. PubMed ID: 19789449
    [Abstract] [Full Text] [Related]

  • 10. Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction.
    Marshall CJ, Nallaratnam M, Mocatta T, Smyth D, Richards M, Elliott JM, Blake J, Winterbourn CC, Kettle AJ, McClean DR.
    Am J Cardiol; 2010 Aug 01; 106(3):316-22. PubMed ID: 20643239
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mitral regurgitation is an independent predictor of 1-year mortality in ST-elevation myocardial infarction patients presenting in cardiogenic shock on admission.
    Engström AE, Vis MM, Bouma BJ, Claessen BE, Sjauw KD, Baan J, Meuwissen M, Koch KT, de Winter RJ, Tijssen JG, Piek JJ, Henriques JP.
    Acute Card Care; 2010 Jun 01; 12(2):51-7. PubMed ID: 20482326
    [Abstract] [Full Text] [Related]

  • 13. Diurnal variation of circulating myeloperoxidase levels in patients with ST-segment elevation myocardial infarction.
    Dominguez-Rodriguez A, Abreu-Gonzalez P, Kaski JC.
    Int J Cardiol; 2010 Oct 29; 144(3):407-9. PubMed ID: 19344969
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: a propensity score analysis.
    Chiu FC, Chang SN, Lin JW, Hwang JJ, Chen YS.
    J Thorac Cardiovasc Surg; 2009 Dec 29; 138(6):1326-30. PubMed ID: 19660378
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Emergency percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by out-of-hospital cardiac arrest: early and medium-term outcome.
    Lettieri C, Savonitto S, De Servi S, Guagliumi G, Belli G, Repetto A, Piccaluga E, Politi A, Ettori F, Castiglioni B, Fabbiocchi F, De Cesare N, Sangiorgi G, Musumeci G, Onofri M, D'Urbano M, Pirelli S, Zanini R, Klugmann S, LombardIMA Study Group.
    Am Heart J; 2009 Mar 29; 157(3):569-575.e1. PubMed ID: 19249431
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Time-dependent changes of myeloperoxidase in relation to in-hospital mortality in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Stankovic S, Asanin M, Trifunovic D, Majkic-Singh N, Ignjatovic S, Mrdovic I, Matic D, Savic L, Marinkovic J, Ostojic M, Vasiljevic Z.
    Clin Biochem; 2012 May 29; 45(7-8):547-51. PubMed ID: 22394459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.